See more : Triangle Energy (Global) Limited (TEG.AX) Income Statement Analysis – Financial Results
Complete financial analysis of AlerisLife Inc. (ALR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of AlerisLife Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- FDM Group (Holdings) plc (FDDMF) Income Statement Analysis – Financial Results
- Zhejiang Fenglong Electric Co., Ltd. (002931.SZ) Income Statement Analysis – Financial Results
- Colfax Corporation (CFX) Income Statement Analysis – Financial Results
- Shanghai Hongda New Material Co., Ltd. (002211.SZ) Income Statement Analysis – Financial Results
- Bauba Resources Limited (BAU.JO) Income Statement Analysis – Financial Results
AlerisLife Inc. (ALR)
About AlerisLife Inc.
AlerisLife Inc. operates and manages senior living communities in the United States. It operates through two segments, Residential and Lifestyle Services. Its senior living communities comprise independent living communities, assisted living communities, memory care, continuing care retirement communities (CCRCs), skilled nursing facilities (SNFs), and an active adult community. The company offers nursing and healthcare services; and outpatient rehabilitation clinics and fitness services. As of December 31, 2021, it owned and operated or managed, 141 senior living communities located in 28 states with 20,105 living units, including 10,423 independent living apartments, 9,636 assisted living suites, which includes 1,872 of Bridge to Rediscovery memory care units, and one continuing CCRC, with 106 living units, including 46 SNF. The company was formerly known as Five Star Senior Living Inc. and changed its name to AlerisLife Inc. in January 2022. AlerisLife Inc. was incorporated in 2001 and is headquartered in Newton, Massachusetts.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 934.59M | 1.16B | 1.42B | 1.39B | 1.40B | 1.38B | 1.37B | 1.33B | 1.30B | 1.35B | 1.28B | 1.24B | 1.19B | 1.10B | 972.92M | 827.34M | 757.53M | 628.01M | 576.22M | 522.51M | 229.24M |
| Cost of Revenue | 851.46M | 1.05B | 1.19B | 1.15B | 1.10B | 1.08B | 1.07B | 1.05B | 1.00B | 1.04B | 449.95M | 954.29M | 934.93M | 863.39M | 763.10M | 263.90M | 183.89M | 159.89M | 151.01M | 182.54M | 72.97M |
| Gross Profit | 83.13M | 115.79M | 229.87M | 245.05M | 291.74M | 297.77M | 292.11M | 282.99M | 294.80M | 309.16M | 831.82M | 286.44M | 257.63M | 240.81M | 209.82M | 563.44M | 573.64M | 468.11M | 425.20M | 339.97M | 156.27M |
| Gross Profit Ratio | 8.90% | 9.95% | 16.24% | 17.62% | 20.90% | 21.61% | 21.39% | 21.31% | 22.73% | 22.89% | 64.90% | 23.09% | 21.60% | 21.81% | 21.57% | 68.10% | 75.72% | 74.54% | 73.79% | 65.06% | 68.17% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 85.72M | 92.29M | 229.37M | 287.34M | 281.74M | 275.18M | 269.83M | 269.74M | 257.33M | 263.24M | 789.34M | 243.87M | 231.46M | 207.54M | 43.37M | 33.83M | 27.78M | 20.05M | 0.00 | 0.00 | 15.42M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 129.19M | 504.23M | 615.46M | 441.07M | 0.00 | 0.00 | 139.10M |
| SG&A | 85.72M | 92.29M | 229.37M | 287.34M | 281.74M | 275.18M | 269.83M | 269.74M | 257.33M | 263.24M | 789.34M | 243.87M | 231.46M | 207.54M | 172.56M | 538.06M | 643.24M | 461.12M | 428.02M | 345.16M | 154.51M |
| Other Expenses | 4.08M | 7.56M | 16.64M | 35.94M | 38.19M | 38.05M | 33.82M | 31.83M | 27.02M | 25.06M | 21.13M | 16.80M | 16.38M | 8.79M | 13.60M | 139.86M | 7.11M | 3.67M | 3.59M | 1.89M | 1.27M |
| Operating Expenses | 89.80M | 99.85M | 246.01M | 323.28M | 319.94M | 313.24M | 303.65M | 301.58M | 284.35M | 288.30M | 810.47M | 260.67M | 247.84M | 216.33M | 186.16M | 677.92M | 650.35M | 464.79M | 431.61M | 347.05M | 155.78M |
| Cost & Expenses | 941.26M | 1.15B | 1.43B | 1.47B | 1.42B | 1.39B | 1.38B | 1.35B | 1.29B | 1.33B | 1.26B | 1.21B | 1.18B | 1.08B | 949.26M | 941.82M | 834.24M | 624.68M | 582.62M | 529.59M | 228.75M |
| Interest Income | 358.00K | 757.00K | 1.36M | 818.00K | 765.00K | 984.00K | 982.00K | 867.00K | 781.00K | 881.00K | 1.30M | 1.82M | 2.99M | 5.92M | 6.15M | 6.81M | 1.54M | 1.67M | 229.00K | 297.00K | 43.00K |
| Interest Expense | 1.68M | 1.63M | 2.62M | 3.02M | 4.31M | 4.91M | 4.93M | 5.13M | 5.23M | 6.27M | 3.92M | 3.05M | 4.37M | 6.34M | 6.80M | 4.37M | 3.74M | 880.00K | 1.16M | 198.00K | 198.00K |
| Depreciation & Amortization | 11.87M | 11.75M | 16.64M | 35.94M | 38.19M | 38.05M | 33.67M | 33.47M | 28.11M | 25.06M | 21.13M | 16.80M | 16.38M | 14.72M | 13.60M | 9.95M | 7.11M | 3.67M | 3.59M | 1.89M | 1.32M |
| EBITDA | 5.57M | 27.70M | 1.87M | -34.88M | 17.06M | 23.50M | -3.82M | 9.58M | 32.91M | 61.92M | 38.69M | 44.79M | 61.27M | 17.95M | 45.13M | -102.35M | -73.30M | 7.96M | -3.19M | -11.09M | 1.85M |
| EBITDA Ratio | 0.60% | 2.38% | 0.13% | -2.51% | 1.22% | 1.71% | -0.28% | 0.72% | 2.54% | 4.58% | 3.02% | 3.61% | 5.14% | 1.63% | 4.64% | -12.37% | -9.68% | 1.27% | -0.55% | -2.12% | 0.81% |
| Operating Income | -6.31M | 15.94M | -14.77M | -71.56M | -23.05M | -15.97M | -37.02M | -19.18M | 10.26M | 20.86M | 21.35M | 25.77M | 9.80M | 18.55M | 23.66M | -114.48M | -76.71M | 3.32M | -6.40M | -10.03M | 484.00K |
| Operating Income Ratio | -0.67% | 1.37% | -1.04% | -5.15% | -1.65% | -1.16% | -2.71% | -1.44% | 0.79% | 1.54% | 1.67% | 2.08% | 0.82% | 1.68% | 2.43% | -13.84% | -10.13% | 0.53% | -1.11% | -1.92% | 0.21% |
| Total Other Income/Expenses | -23.21M | -22.87M | -5.74M | -2.79M | -2.99M | -3.82M | -3.09M | -3.87M | -5.23M | -1.79M | -3.63M | 441.00K | 31.66M | -16.74M | 3.84M | 2.44M | -4.53M | 786.00K | 0.00 | -348.00K | 43.00K |
| Income Before Tax | -29.51M | -6.93M | -20.51M | -74.35M | -26.05M | -19.79M | -40.12M | -23.05M | 5.03M | 19.07M | 17.72M | 26.21M | 41.45M | 1.82M | 27.51M | -112.04M | -81.25M | 4.11M | 0.00 | -10.38M | 527.00K |
| Income Before Tax Ratio | -3.16% | -0.60% | -1.45% | -5.35% | -1.87% | -1.44% | -2.94% | -1.74% | 0.39% | 1.41% | 1.38% | 2.11% | 3.48% | 0.16% | 2.83% | -13.54% | -10.73% | 0.65% | 0.00% | -1.99% | 0.23% |
| Income Tax Expense | 234.00K | 663.00K | 56.00K | 247.00K | -4.54M | 2.35M | 662.00K | 56.39M | 1.92M | 5.64M | -50.55M | 1.45M | 2.20M | 1.39M | 1.41M | 4.63M | 2.91M | 120.00K | 1.16M | -150.00K | 2.80M |
| Net Income | -29.75M | -7.59M | -20.57M | -74.08M | -20.90M | -21.81M | -43.08M | -85.41M | -2.34M | 24.95M | 64.20M | 23.49M | 38.33M | -4.50M | 23.33M | -116.67M | -84.16M | 3.29M | -7.94M | -13.17M | 527.00K |
| Net Income Ratio | -3.18% | -0.65% | -1.45% | -5.33% | -1.50% | -1.58% | -3.16% | -6.43% | -0.18% | 1.85% | 5.01% | 1.89% | 3.21% | -0.41% | 2.40% | -14.10% | -11.11% | 0.52% | -1.38% | -2.52% | 0.23% |
| EPS | -0.94 | -0.24 | -4.11 | -14.91 | -4.25 | -4.47 | -8.90 | -17.78 | -0.48 | 5.20 | 15.23 | 6.57 | 11.42 | -1.41 | 7.36 | -40.78 | -56.56 | 3.78 | -9.36 | -17.44 | 1.20 |
| EPS Diluted | -0.94 | -0.24 | -4.11 | -14.91 | -4.25 | -4.47 | -8.90 | -17.78 | -0.48 | 5.20 | 14.26 | 5.99 | 9.89 | -1.41 | 5.63 | -40.78 | -56.56 | 3.78 | -9.36 | -17.44 | 1.20 |
| Weighted Avg Shares Out | 31.59M | 31.47M | 5.01M | 4.97M | 4.92M | 4.88M | 4.84M | 4.80M | 4.83M | 4.80M | 4.22M | 3.57M | 3.36M | 3.19M | 3.17M | 2.86M | 1.49M | 871.60K | 848.20K | 755.60K | 437.40K |
| Weighted Avg Shares Out (Dil) | 31.59M | 31.47M | 5.01M | 4.97M | 4.92M | 4.88M | 4.84M | 4.80M | 4.93M | 4.80M | 4.50M | 3.92M | 3.88M | 3.19M | 4.14M | 2.86M | 1.49M | 871.60K | 848.20K | 755.60K | 437.40K |
AlerisLife Inc. Announces Second Quarter 2022 Results
NEWTON, Mass.--(BUSINESS WIRE)--AlerisLife Inc. (Nasdaq: ALR) today announced its financial results for the three months ended June 30, 2022. “Our second quarter results reflect progress in critical performance areas,” said Jeff Leer, President, Chief Executive Officer and Chief Financial Officer....
AlerisLife Inc. Announces Second Quarter 2022 Results
NEWTON, Mass.--(BUSINESS WIRE)--AlerisLife Inc. (Nasdaq: ALR) today announced its financial results for the three months ended June 30, 2022. “Our second quarter results reflect progress in critical performance areas,” said Jeff Leer, President, Chief Executive Officer and Chief Financial Officer....
AlerisLife Inc. Announces Second Quarter 2022 Results
NEWTON, Mass.--(BUSINESS WIRE)--AlerisLife Inc. (Nasdaq: ALR) today announced its financial results for the three months ended June 30, 2022. “Our second quarter results reflect progress in critical performance areas,” said Jeff Leer, President, Chief Executive Officer and Chief Financial Officer....
AlerisLife Inc. Second Quarter 2022 Conference Call Scheduled for Thursday, August 4th
NEWTON, Mass.--(BUSINESS WIRE)--AlerisLife Inc. (Nasdaq: ALR) today announced that it will issue a press release containing its second quarter 2022 financial results after the Nasdaq closes on Wednesday, August 3, 2022. On Thursday, August 4, 2022 at 1:00 p.m. Eastern...
AlerisLife Inc. Second Quarter 2022 Conference Call Scheduled for Thursday, August 4th
NEWTON, Mass.--(BUSINESS WIRE)--AlerisLife Inc. (Nasdaq: ALR) today announced that it will issue a press release containing its second quarter 2022 financial results after the Nasdaq closes on Wednesday, August 3, 2022. On Thursday, August 4, 2022 at 1:00 p.m. Eastern...
AlerisLife Provides a Business Update
NEWTON, Mass.--(BUSINESS WIRE)--AlerisLife Inc. (Nasdaq: ALR) today announced that Jeff Leer has been appointed President and Chief Executive Officer. Mr. Leer had previously been appointed President and Chief Executive Officer on an interim basis. Mr. Leer will also continue to...
AlerisLife Provides a Business Update
NEWTON, Mass.--(BUSINESS WIRE)--AlerisLife Inc. (Nasdaq: ALR) today announced that Jeff Leer has been appointed President and Chief Executive Officer.
AlerisLife Inc. Announces Annual Meeting Results
NEWTON, Mass.--(BUSINESS WIRE)--AlerisLife Inc. (Nasdaq: ALR) announced the results of its 2022 Annual Meeting of Stockholders which was held today. Bruce M. Gans, M.D. was re-elected as an Independent Director. The final tabulation of the percentage of stockholders' votes cast...
AlerisLife Inc. Announces Annual Meeting Results
NEWTON, Mass.--(BUSINESS WIRE)--AlerisLife Inc. (Nasdaq: ALR) announced the results of its 2022 Annual Meeting of Stockholders which was held today. Bruce M. Gans, M.D. was re-elected as an Independent Director. The final tabulation of the percentage of stockholders’ votes cast...
AlerisLife’s Five Star Senior Living Communities Receive National Recognition
NEWTON, Mass.--(BUSINESS WIRE)--AlerisLife (Nasdaq: ALR) today announced that U.S. News and World Report has recognized 53 communities from AlerisLife’s operating division, Five Star Senior Living, with the highest possible rating in its inaugural “Best Senior Living” ratings. The list reflects...
Source: https://incomestatements.info
Category: Stock Reports